Recro Pharma (REPH)

Earnings in 2021 (TTM): HK$29.23 Million

According to Recro Pharma 's latest financial reports the company's current earnings are HK$75.36 Million. In 2020 the company made an earning of -HK$65.14 Million a decrease over its 2019 earnings that were of HK$0.19 Billion.

Earnings history for Recro Pharma from 2013 to 2021

Annual earnings

Year	Earnings	Change
2021 (TTM)	HK$29.23 M	-144.89%
2020	-HK$65.14 Million	-134.02%
2019	HK$0.19 B	-145.64%
2018	-HK$0.42 Billion	34.08%
2017	-HK$0.32 Billion	55.21%
2016	-HK$0.21 Billion	258.83%
2015	-HK$56.18 Million	-39.6%
2014	-HK$93.01 Million	989.11%
2013	-HK$8.54 Million

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Johnson & Johnson JNJ	HK$203.57 B	690,096.60%	🇺🇸 USA
Pacira Biosciences PCRX	HK$0.13 B	348.30%	🇺🇸 USA
Flexion Therapeutics FLXN	-HK$0.63 Billion	-2,209.14%	🇺🇸 USA
AcelRx Pharmaceuticals ACRX	-HK$80.62 Million	-373.30%	🇺🇸 USA
Cara Therapeutics CARA	-HK$0.5 Billion	-1,768.23%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for Recro Pharma (REPH)

Earnings in 2021 (TTM): HK$29.23 Million